CDK5 and Alzheimer disease: For example, Cdk5 inhibitor roscovitine and small peptides that can disrupt Cdk5/p35/p25 interaction have been used for AD intervention (Sundaram et al., 2013; Tell and Hilgeroth, 2013; Shukla et al., 2017).